The Nasdaq 100 trades at records Monday, yet 55 of its 101 stocks sit below their 50-day average. QQ

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet h

Transaction marks the first realization from the now closed specialist animal health fund's inaugura

IDEXX's CAG growth, expanding software adoption and global gains face headwinds from FX and weaker U

IDEXX Laboratories (NASDAQ: IDXX) executives highlighted the company's diagnostic innovation pipelin

IDEXX Laboratories (NASDAQ: IDXX) executives reiterated the company's long-term growth framework at

IDEXX Laboratories NASDAQ: IDXX executives highlighted the company's diagnostic innovation pipeline,

IDEXX Laboratories NASDAQ: IDXX executives reiterated the company's long-term growth framework at th

IDXX shares rise 0.6% after the company acquires CoVet, expanding its AI-native software capabilitie

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announc

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX expands Faecal Dx™ antigen testing platform in the United K

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX announces acquisition of CoVetAI to advance veterinary work

IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference

InMode (NASDAQ: INMD - Get Free Report) and IDEXX Laboratories (NASDAQ: IDXX - Get Free Report) are

The transaction involved 2,203 shares at $532.08 per share for a total value of ~$1.2 million. The d

Baird Financial Group Inc. decreased its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 7.9%

Arizona State Retirement System raised its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 4.

California State Teachers Retirement System raised its holdings in shares of IDEXX Laboratories, Inc

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?

Baron Focused Growth Fund rebounded in Q2 from a disappointing start to the year, with the Fund gain

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet h

Barclays analyst Glen Santangelo maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises t

Citigroup analyst Daniel Grosslight maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and

IDEXX Laboratories (IDXX) stock rose after reporting Q2 earnings of $4.27/share and $1.22B in revenu

IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter financial results on Tuesday. The transcrip

IDEXX Laboratories (NASDAQ:IDXX) raises FY2026 GAAP EPS guidance from $14.45-$14.90 to $14.69-$14.94

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $4.27 per share which beat the analy

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t

Idexx Laboratories shares edge higher as revenue tops estimates but earnings per share misses; guida

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $3.47 per share which beat the analy

IDEXX Laboratories (NASDAQ:IDXX) raises FY2026 GAAP EPS guidance from $14.29-$14.80 to $14.45-$14.90

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t

Citigroup analyst Daniel Grosslight initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a

Stifel analyst Jonathan Block maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers th

Piper Sandler analyst David Westenberg maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral

Barclays analyst Glen Santangelo maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t

BTIG analyst Mark Massaro maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers the pr

Dow Jones gains 500 points. Markets digest Trump's Fed chair nomination. CNN Money Fear & Gr

Wall Street rebounded at the start of the new month after Friday's broad sell-off, but pressure

IDEXX beat earnings and revenue estimates, boosted by strong pet diagnostics growth, and forecast so